ArticleBriefings in bioinformatics2025
Identifying survival subtypes with autoencoder using multiple types of high-dimensional genomic data from studies of glioblastoma multiforme.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Analysis of multiple types of omics data facilitates a comprehensive revelation of molecular-level complexity and interactions among genomic features. This knowledge promotes the development of new therapies for treating different genomic diseases. An integrative study of multiple types of genomic data instead of a single type of genomic data will be more informative in understanding the complicated molecular activities and their interactions. In this work, we integrated RNA-sequencing (RNA-seq), methylation, and DNA copy number variation data, downloaded from the TCGA public repository, of glioblastoma multiforme (GBM), reduced the dimension of these high-dimensional genomic data using an autoencoder, a deep learning-based method, and then used Cox-PH model to select the autoencoder-transformed features that have a significant contribution to patient survival. We utilized the significant set of autoencoder-transformed features to classify the survival subtypes using the integrated data. We built a classification model with a penalization technique, sparse group LASSO, and evaluated the approach using cross-validation. As a result, two survival subgroups, with overall different survival profiles and linking to various genomic features, are discovered for respective GBM patients. Finally, the results are interpreted biologically by differential expression analysis and pathway analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.